Cellares Corporation, a life science technology company leading the way in cell therapy manufacturing automation, and iVexSol Inc., a company developing transformative viral vector manufacturing capabilities, today announced a strategic partnership to solve key challenges with viral vector manufacturing in order to accelerate access to life-saving therapies.